Stock data
MBX Biosciences, Inc. (MBX)
MBX Biosciences, Inc. (MBX) reported net income of -US$86.97M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$98.06M | -US$86.97M | — |
| 2024 | — | — | -US$68.19M | -US$61.92M | — |
| 2023 | — | — | -US$35.31M | -US$32.56M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$37.09M | — |
| 2026-03-31 | — | -US$23.52M | — |
| 2025-12-31 | — | -US$22.06M | — |
| 2025-09-30 | — | -US$21.62M | — |
| 2025-06-30 | — | -US$19.41M | — |
| 2025-03-31 | — | -US$23.88M | — |
| 2024-12-31 | — | -US$15.59M | — |
| 2024-09-30 | — | -US$18.14M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.